Beta-synuclein is a neuronal protein that accumulates in the plaques that characterize neurodegenerative diseases such as Parkinson's and Alzheimer's diseases. It has been proposed that immunization to peptides of plaque-forming proteins might be used therapeutically to help dissociate pathogenic plaques in the brain. We now report that immunization of Lewis rats with a peptide from beta-synuclein resulted in acute paralytic encephalomyelitis and uveitis. T cell lines and clones reactive to the peptide adoptively transferred the disease to naive rats. Immunoblotting revealed the presence of beta-synuclein in heavy myelin, indicating that the expression of beta-synuclein is not confined to neurons. These results add beta-synuclein to the roster of encephalitogenic self Ags, point out the potential danger of therapeutic autoimmunization to beta-synuclein, and alert us to the unsuspected possibility that autoimmunity to beta-synuclein might play an inflammatory role in the pathogenesis of neurodegeneration.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.4049/jimmunol.170.1.628 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Clinical spectrum and evolution of immune-checkpoint inhibitors toxicities over a decade-a worldwide perspective.
EClinicalMedicine
April 2024
Sorbonne Université, Institut National de la Santé et de la Recherche Médicale (INSERM), Assistance Publique - Hôpitaux de Paris (AP-HP), Clinical Investigation Center (CIC-1901), Regional Pharmacovigilance Centre, Department of Pharmacology, Pitié-Salpêtrière Hospital, Paris, France.
Article Synopsis
- Immune-checkpoint inhibitors (ICI) have transformed cancer treatment by utilizing the immune system, but they can cause serious, life-threatening immune-related adverse events (irAE) that can affect various organs.
- Analysis of data from the international pharmacovigilance database revealed 25 types of irAE across over 50,000 cases, with skin reactions and pneumonitis being the most common, and a shift in treatment regimens favoring anti-PD1 and anti-PDL1 therapies after 2016.
- Specific risk factors for certain irAE include cancer types and treatment regimens, with a median onset time for complications varying greatly; this underscores the importance of monitoring during ICI therapy
Eugenol ameliorates uveitis in mice with experimental autoimmune encephalomyelitis through the suppression of key inflammatory genes.
Anim Cells Syst (Seoul)
January 2024
College of Veterinary Medicine and Veterinary Medical Research Institute, Jeju National University, Jeju, Republic of Korea.
Visual impairment associated with uveitis is among the potential complications in multiple sclerosis (MS) and its animal model, experimental autoimmune encephalomyelitis (EAE). Bioinformatics analyses have shown that some hub genes are closely associated with the molecular mechanisms underlying uveitis in EAE. This study evaluated whether 4-allyl-2-methoxyphenol (eugenol) can mitigate the pathogenesis of uveitis in EAE through the interruption of key uveitogenic gene expression.
View Article and Find Full Text PDFGateway reflexes describe novel neuro-immune communications that establish immune cell gateways at specific vessels.
Bioelectron Med
November 2023
Division of Molecular Psychoimmunology, Institute for Genetic Medicine and Graduate School of Medicine, Hokkaido University, Kita-15, Nishi-7, Kita-Ku, Sapporo, 060-0815, Japan.
Neuroinflammation is an important biological process induced by complex interactions between immune cells and neuronal cells in the central nervous system (CNS). Recent research on the bidirectional communication between neuronal and immunological systems has provided evidence for how immune and inflammatory processes are regulated by nerve activation. One example is the gateway reflex, in which immune cells bypass the blood brain barrier and infiltrate the CNS to cause neuroinflammation.
View Article and Find Full Text PDFRetinal transcriptome profiling identifies novel candidate genes associated with visual impairment in a mouse model of multiple sclerosis.
Anim Cells Syst (Seoul)
October 2023
Department of Veterinary Anatomy, College of Veterinary Medicine and Veterinary Medical Research Institute, Jeju National University, Jeju, Republic of Korea.
Visual impairment is occasionally observed in multiple sclerosis (MS) and its animal model, experimental autoimmune encephalomyelitis (EAE). Although uveitis and optic neuritis have been reported in MS and EAE, the precise mechanisms underlying the pathogenesis of these visual impairments remain poorly understood. This study aims to identify differentially expressed genes (DEGs) in the retinas of mice with EAE to identify genes that may be implicated in EAE-induced visual impairment.
View Article and Find Full Text PDFCan early-onset acquired demyelinating syndrome (ADS) hide pediatric Behcet's disease? A case report.
Front Pediatr
June 2023
Pediatric Immunorheumatology Unit, Fondazione IRCCS Ca' Granda ospedale Maggiore Policlinico, Milan, Italy.
Article Synopsis
- Behcet's disease (BD) is a rare condition marked by widespread inflammation; neurological symptoms, especially in children, are infrequent and can complicate diagnosis.
- The case study highlights a 13-month-old girl with severe neurological episodes that initially resembled acute disseminated encephalomyelitis, before evolving into signs indicative of Behcet's disease such as polyarthritis and uveitis.
- Successful treatment involved a team of specialists and emphasized the importance of recognizing early-onset demyelinating syndromes and the need for a thorough literature review on BD's neurological aspects.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!